Spectrum Brands Holdings Reports Fiscal 2018 Third Quarter Results from Continuing Operations
Effective
This press release includes non-GAAP metrics such as organic net sales, adjusted diluted earnings per share (EPS), adjusted EBITDA, adjusted EBITDA margin, organic adjusted EBITDA and adjusted free cash flow. See Other Supplemental Information for reconciliation to comparable GAAP metrics.
Fiscal 2018 Third Quarter Highlights from Continuing Operations:
-
Net sales of
$945.5 million in the third quarter of fiscal 2018 increased 9.6 percent compared to$862.9 million last year. Excluding the impact of$4.9 million of favorable foreign exchange and acquisition sales of$14.5 million , organic net sales increased 7.3 percent versus the prior year. -
Net income from continuing operations of
$377.4 million and diluted EPS from continuing operations of$11.51 in the third quarter of fiscal 2018 increased compared to a net loss from continuing operations of$16.6 million and diluted loss per share from continuing operations of($0.51) in fiscal 2017 primarily due to increased operating income, changes in the U.S. corporate tax rate, and release of HRG valuation allowances. -
Adjusted diluted EPS from continuing operations of
$1.76 in the third quarter of fiscal 2018 increased 23.9 percent versus$1.42 last year predominantly due to higher gross profit and changes in the U.S. corporate tax rate. -
Operating income of
$126.3 million in the third quarter of fiscal 2018 increased 25.4 percent versus$100.7 million last year primarily as a result of higher volumes. - Operating income margin of 13.4 percent in the third quarter of fiscal 2018 increased 170 basis points versus 11.7 percent last year.
-
Adjusted EBITDA of
$206.4 million in the third quarter of fiscal 2018 increased 3.6 percent compared to$199.3 million in fiscal 2017. Excluding the impact of favorable foreign exchange of$0.4 million and acquisition EBITDA of$5.6 million , organic adjusted EBITDA of$200.4 million increased 0.6 percent versus the prior year. - Adjusted EBITDA margin of 21.8 percent in the third quarter of fiscal 2018 decreased 130 basis points compared to 23.1 percent in fiscal 2017 primarily due to operating inefficiencies, input cost inflation and higher distribution costs.
“I am pleased to report to you today that the turnaround of our HHI and
GAC business units is well under way," said
“As we are regaining operating momentum, we are on track to deliver the
improved performance we promised in the second half of this fiscal
year,” Maura said. “As such, we reiterate our fiscal 2018 adjusted
EBITDA guidance for continuing operations of
“Led by double-digit growth in our HHI and Auto Care businesses and a
strong top line in Home & Garden, we reported our highest organic sales
growth rate in many years in the third quarter, our largest fiscal
quarter, as we experienced solid market demand for our brands and
benefited from markedly reduced order backlogs in
“I am particularly pleased with our EBITDA margin recovery in our GAC business as we rebounded from a 16% EBITDA margin in our second quarter to a 28.6% EBITDA margin in the third quarter,” Maura said. “We have much more work to do in Dayton, but we are on our way and the business is rebounding, proving the issues we faced were indeed largely transitory.
“As we anniversary our rawhide recall, I continue to be bullish on the outlook for our Pet unit. This quarter’s results, however, were impacted by short-term, start-up issues in late April and May with the consolidation of our European aquatics and pet distribution centers in the Netherlands,” said Maura. “The temporary customer order backlog that developed in the third quarter we expect to ship in the fourth quarter as this facility returns to normal operating rhythm. Our U.S. Pet business delivered encouraging results in the third quarter, with our PetMatrix and Glofish acquisitions leading the way and last year’s rawhide recall now essentially behind us.
“Our tax-free merger with
“We remain on track to close the sale of our Global Battery and Lighting
business to
“The significant net proceeds we will receive from these divestitures,” Maura said, “will be used to reduce debt, repurchase shares, and increase investment in organic growth initiatives and bolt-on acquisitions in our four higher-margin and faster-growing remaining businesses.”
Fiscal 2018 Third Quarter Consolidated Financial Results from Continuing Operations
Net sales of
Gross profit and gross profit margin in the third quarter of fiscal 2018
were
Operating expenses of
Net income from continuing operations was
As a result of the lower U.S. corporate tax rate due to recently enacted tax reform, fiscal 2018 adjusted EPS reflects a 24.5 percent blended tax rate versus 35.0 percent used in previous years.
Adjusted EBITDA of
Fiscal 2018 Nine Months Consolidated Financial Results from Continuing Operations
Net sales of
Operating income of
Net income from continuing operations was
Fiscal 2018 nine months adjusted EBITDA from continuing operations of
Fiscal 2018 Third Quarter Segment Level Data
Hardware & Home Improvement (HHI) |
||||||||||||||||||||||||||||||
Three Month Periods Ended | Nine Month Periods Ended | |||||||||||||||||||||||||||||
(in millions, except %) | June 30, 2018 | June 30, 2017 | Variance | June 30, 2018 | June 30, 2017 | Variance | ||||||||||||||||||||||||
Net Sales | $ | 372.4 | $ | 324.7 | $ | 47.7 | 14.7 | % | $ | 1,016.8 | $ | 927.2 | $ | 89.6 | 9.7 | % | ||||||||||||||
Operating Income | 51.1 | 45.1 | 6.0 | 13.3 | % | 102.4 | 137.4 | (35.0 | ) | (25.5 | %) | |||||||||||||||||||
Operating Income Margin | 13.7 | % | 13.9 | % | (20 | ) | bps | 10.1 | % | 14.8 | % | (470 | ) | bps | ||||||||||||||||
Adjusted EBITDA | 73.9 | 62.2 | 11.7 | 18.8 | % | 179.5 | 178.0 | 1.5 | 0.8 | % | ||||||||||||||||||||
Adjusted EBITDA Margin | 19.8 | % | 19.2 | % | 60 | bps | 17.7 | % | 19.2 | % | (150 | ) | bps | |||||||||||||||||
Significantly increased third quarter net sales were due to continued
strong demand in residential security and plumbing in the U.S. and
Increases in third quarter operating income, adjusted EBITDA and adjusted EBITDA margin were primarily a result of higher volumes.
Global Pet Supplies (PET) |
|||||||||||||||||||||||||||||
Three Month Periods Ended | Nine Month Periods Ended | ||||||||||||||||||||||||||||
(in millions, except %) | June 30, 2018 | June 30, 2017 | Variance | June 30, 2018 | June 30, 2017 | Variance | |||||||||||||||||||||||
Net Sales | $ | 194.7 | $ | 190.0 | $ | 4.7 | 2.5 | % | $ | 608.3 | $ | 576.0 | $ | 32.3 | 5.6 | % | |||||||||||||
Operating Income | 15.0 | (5.2 | ) | 20.2 | (388.5 | %) | 42.8 | 34.4 | 8.4 | 24.4 | % | ||||||||||||||||||
Operating Income Margin | 7.7 | % | (2.7 | %) | 1,040 | bps | 7.0 | % | 6.0 | % | 100 | bps | |||||||||||||||||
Adjusted EBITDA | 34.9 | 36.1 | (1.2 | ) | (3.3 | %) | 104.6 | 98.7 | 5.9 | 6.0 | % | ||||||||||||||||||
Adjusted EBITDA Margin | 17.9 | % | 19.0 | % | (110 | ) | bps | 17.2 | % | 17.1 | % | 10 | bps | ||||||||||||||||
Third quarter net sales increased as a result of revenues from the
PetMatrix and GloFish acquisitions completed in June and
Increased operating income and margin were primarily driven by the
impact in the prior year of the U.S. rawhide recall. Adjusted EBITDA and
margin decreased as a result of lower volumes and unfavorable mix.
Excluding unfavorable foreign exchange impacts of
Home and Garden (H&G) |
||||||||||||||||||||||||||||||
Three Month Periods Ended | Nine Month Periods Ended | |||||||||||||||||||||||||||||
(in millions, except %) | June 30, 2018 | June 30, 2017 | Variance | June 30, 2018 | June 30, 2017 | Variance | ||||||||||||||||||||||||
Net Sales | $ | 203.2 | $ | 192.4 | $ | 10.8 | 5.6 | % | $ | 370.6 | $ | 374.2 | $ | (3.6 | ) | (1.0 | %) | |||||||||||||
Operating Income | 52.2 | 55.3 | (3.1 | ) | (5.6 | %) | 73.3 | 88.4 | (15.1 | ) | (17.1 | %) | ||||||||||||||||||
Operating Income Margin | 25.7 | % | 28.7 | % | (300 | ) | bps | 19.8 | % | 23.6 | % | (380 | ) | bps | ||||||||||||||||
Adjusted EBITDA | 57.0 | 59.5 | (2.5 | ) | (4.2 | %) | 87.7 | 100.8 | (13.1 | ) | (13.0 | %) | ||||||||||||||||||
Adjusted EBITDA Margin | 28.1 | % | 30.9 | % | (280 | ) | bps | 23.7 | % | 26.9 | % | (320 | ) | bps | ||||||||||||||||
Higher third quarter net sales were driven by strong growth in outdoor and household control product category revenues.
Lower operating income, adjusted EBITDA and margins decreased predominantly due to unfavorable product mix and higher input costs.
Global Auto Care (GAC) |
||||||||||||||||||||||||||||||||||||||||||||
Three Month Periods Ended | Nine Month Periods Ended | |||||||||||||||||||||||||||||||||||||||||||
(in millions, except %) | June 30, 2018 | June 30, 2017 | Variance | June 30, 2018 | June 30, 2017 | Variance | ||||||||||||||||||||||||||||||||||||||
Net Sales | $ | 175.2 | $ | 155.8 | $ | 19.4 | 12.5 | % | $ | 362.4 | $ | 344.2 | $ | 18.2 | 5.3 | % | ||||||||||||||||||||||||||||
Operating Income | 38.6 | 32.5 | 6.1 | 18.8 | % | 57.3 | 80.1 | (22.8 | ) | (28.5 | %) | |||||||||||||||||||||||||||||||||
Operating Income Margin | 22.0 | % | 20.9 | % | 110 | bps | 15.8 | % | 23.3 | % | (750 | ) | bps | |||||||||||||||||||||||||||||||
Adjusted EBITDA | 50.1 | 50.7 | (0.6 | ) | (1.2 | %) | 84.7 | 115.9 | (31.2 | ) | (26.9 | %) | ||||||||||||||||||||||||||||||||
Adjusted EBITDA Margin | 28.6 | % | 32.5 | % | (390 | ) | bps | 23.4 | % | 33.7 | % | (1,030 | ) | bps | ||||||||||||||||||||||||||||||
The strong increase in third quarter net sales was driven by
double-digit growth in refrigerant revenues as well as improved
performance chemical sales. Also contributing to the growth was the
elimination of the customer order backlog at the Dayton facility.
Excluding favorable foreign exchange impacts of
Improved operating income and margin were the result of higher volumes. The lower adjusted EBITDA margin was predominantly driven by higher refrigerant and other input costs and increased Project Alpha marketing investments.
Fiscal 2018 Third Quarter and Nine Months Consolidated Financial Results from GBA Discontinued Operations
A loss from GBA discontinued operations, net of tax, of
Income from GBA discontinued operations, net of tax, of
Liquidity and Debt
As of the end of the third quarter of fiscal 2018, the Company had
approximately
Fiscal 2018 Outlook
Fiscal 2018 adjusted EBITDA from continuing operations is projected to
be approximately
Fiscal 2018 adjusted free cash flow is projected to be approximately
Conference Call/Webcast Scheduled for
A replay of the live webcast also will be accessible through the Event
Calendar page in the Investor Relations section of the Company’s
website. A telephone replay of the conference call will be available
through
About
Non-GAAP Measurements
Management believes that certain non-GAAP financial measures may be useful in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Management believes that organic net sales provide for a more complete understanding of underlying business trends of regional and segment performance by excluding the impact of currency exchange rate fluctuations and the impact of acquisitions. In addition, within this release, including the supplemental information attached hereto, reference is made to adjusted diluted EPS, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), and adjusted EBITDA margin. Adjusted EBITDA is a metric used by management to evaluate segment performance and frequently used by the financial community which provides insight into an organization’s operating trends and facilitates comparisons between peer companies, since interest, taxes, depreciation and amortization can differ greatly between organizations as a result of differing capital structures and tax strategies. Adjusted EBITDA also is one of the measures used for determining the Company’s debt covenant. Adjusted EBITDA excludes certain items that are unusual in nature or not comparable from period to period. Adjusted EBITDA margin reflects adjusted EBITDA as a percentage of net sales of the Company. Organic adjusted EBITDA excludes the impact of currency exchange rate fluctuations and acquisitions. The Company’s management uses adjusted diluted EPS as one means of analyzing the Company’s current and future financial performance and identifying trends in its financial condition and results of operations. Management believes that adjusted diluted EPS is a useful measure for providing further insight into our operating performance because it eliminates the effects of certain items that are not comparable from one period to the next. An income tax adjustment is included in adjusted diluted EPS to exclude the impact of the valuation allowance against deferred taxes and other tax-related items in order to reflect a normalized ongoing effective tax rate. The Company’s management believes that adjusted free cash flow is useful to both management and investors in their analysis of the Company’s ability to service and repay its debt and meet its working capital requirements. Adjusted free cash flow should not be considered in isolation or as a substitute for pretax income, net income, net cash from operating activities or other statement of income or cash flow statement data prepared in accordance with GAAP or as a measure of profitability or liquidity. In addition, the calculation of adjusted free cash flow does not reflect cash used to service debt and therefore, does not reflect funds available for investment or discretionary uses. The Company provides this information to investors to assist in comparisons of past, present and future operating results and to assist in highlighting the results of on-going operations. While the Company’s management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace the Company’s GAAP financial results and should be read in conjunction with those GAAP results. Other Supplemental Information has been provided to demonstrate reconciliation of non-GAAP measurements discussed above to most relevant GAAP financial measurements.
Forward-Looking Statements
Certain matters discussed in this news release and other oral and
written statements by representatives of the Company regarding matters
such as statements under “Fiscal 2018 Outlook” and other statements
regarding the Company’s ability to meet its expectations for its fiscal
2018 (including expectations regarding capital expenditures and its
ability to increase its net sales, free cash flow and adjusted EBITDA)
may be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. We have tried, whenever
possible, to identify these statements by using words like “future,”
“anticipate”, “intend,” “plan,” “estimate,” “believe,” “belief,”
“expect,” “project,” “forecast,” “could,” “would,” “should,” “will,”
“may,” and similar expressions of future intent or the negative of such
terms. These statements are subject to a number of risks and
uncertainties that could cause results to differ materially from those
anticipated as of the date of this release. Actual results may
differ materially as a result of (1) the impact of our indebtedness on
our business, financial condition and results of operations; (2) the
impact of restrictions in our debt instruments on our ability to operate
our business, finance our capital needs or pursue or expand business
strategies; (3) any failure to comply with financial covenants and other
provisions and restrictions of our debt instruments; (4) the impact of
actions taken by significant stockholders; (5) the impact of
fluctuations in commodity prices, costs or availability of raw materials
or terms and conditions available from suppliers, including suppliers’
willingness to advance credit; (6) interest rate and exchange rate
fluctuations; (7) the loss of significant reduction in, or dependence
upon, sales to any significant retail customer(s); (8) competitive
promotional activity or spending by competitors, or price reductions by
competitors; (9) the introduction of new product features or
technological developments by competitors and/or the development of new
competitors or competitive brands; (10) the effects of general economic
conditions, including inflation, recession or fears of a recession,
depression or fears of a depression, labor costs and stock market
volatility or changes in trade, tariff, monetary or fiscal policies in
the countries where we do business; (11) changes in consumer spending
preferences and demand for our products; (12) our ability to develop and
successfully introduce new products, protect our intellectual property
and avoid infringing the intellectual property of third parties; (13)
our ability to successfully implement, achieve and sustain manufacturing
and distribution cost efficiencies and improvements, and fully realize
anticipated cost savings; (14) the seasonal nature of sales of certain
of our products; (15) the effects of climate change and unusual weather
activity; (16) the cost and effect of unanticipated legal, tax or
regulatory proceedings or new laws or regulations (including
environmental, public health and consumer protection regulations); (17)
public perception regarding the safety of products that we manufacture
and sell, including the potential for environmental liabilities, product
liability claims, litigation and other claims related to products
manufactured by us and third parties; (18) the impact of pending or
threatened litigation; (19) the impact of cybersecurity breaches or our
actual or perceived failure to protect company and personal data; (20)
changes in accounting policies applicable to our business; (21) our
ability to utilize net operating loss carry-forwards to offset tax
liabilities from future taxable income; (22) government regulations;
(23) the impact of expenses resulting from the implementation of new
business strategies, divestitures or current and proposed restructuring
activities; (24) our inability to successfully integrate and operate new
acquisitions at the level of financial performance anticipate; (25) the
unanticipated loss of key members of senior management; (26) the effects
of political or economic conditions, terrorist attacks, acts of war or
other unrest in international markets; (27) the Company’s ability to
consummate the announced sale of our Global Battery and Lighting
business on the expected terms and within the anticipated time period,
or at all, which is dependent on the parties’ ability to satisfy certain
closing conditions, including receipt of regulatory approvals, and our
ability to realize the expected benefits of such transaction and to
successfully separate such business; (28) the outcome of the Company’
exploration of strategic options for its Personal Care and Small
Appliances businesses, including uncertainty regarding consummation of
any such transaction or transactions and the terms of such transaction
or transactions, if any, and, if consummated, the Company’s ability to
realize the expected benefits of such transaction or transactions and
potential disruption to our business or diverted management attention as
a result of the exploration or negotiation of such transaction or
transactions; (29) the Company’s ability to realize the expected
benefits from the merger with
SPECTRUM BRANDS HOLDINGS, INC. | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) | ||||||||||||||||
Three Month Periods Ended | Nine Month Periods Ended | |||||||||||||||
(in millions, except per share amounts) | June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | ||||||||||||
Net sales | $ | 945.5 | $ | 862.9 | $ | 2,358.1 | $ | 2,221.6 | ||||||||
Investment income | — | 0.1 | — | 1.1 | ||||||||||||
Revenue | 945.5 | 863.0 | 2,358.1 | 2,222.7 | ||||||||||||
Cost of goods sold | 586.0 | 531.5 | 1,484.5 | 1,339.2 | ||||||||||||
Restructuring and related charges | 4.9 | 11.2 | 9.9 | 16.4 | ||||||||||||
Gross profit | 354.6 | 320.3 | 863.7 | 867.1 | ||||||||||||
Selling | 123.9 | 127.9 | 363.8 | 353.9 | ||||||||||||
General and administrative | 74.7 | 69.3 | 226.9 | 228.6 | ||||||||||||
Research and development | 6.9 | 7.2 | 21.1 | 20.9 | ||||||||||||
Acquisition and integration related charges | 2.3 | 5.2 | 12.0 | 11.6 | ||||||||||||
Restructuring and related charges | 20.5 | 10.0 | 59.1 | 14.9 | ||||||||||||
Total operating expenses | 228.3 | 219.6 | 682.9 | 629.9 | ||||||||||||
Operating income | 126.3 | 100.7 | 180.8 | 237.2 | ||||||||||||
Interest expense | 63.5 | 76.1 | 206.6 | 232.4 | ||||||||||||
Other non-operating (income) expense, net | (2.3 | ) | 1.3 | (4.6 | ) | 1.7 | ||||||||||
Income (loss) from continuing operations before income taxes | 65.1 | 23.3 | (21.2 | ) | 3.1 | |||||||||||
Income tax (benefit) expense | (337.8 | ) | 19.5 | (464.9 | ) | 49.1 | ||||||||||
Net income (loss) from continuing operations | 402.9 | 3.8 | 443.7 | (46.0 | ) | |||||||||||
Income from discontinued operations - FGL, net of tax | 5.9 | 7.7 | 465.9 | 195.4 | ||||||||||||
(Loss) income from discontinued operations - GBA, net of tax | (9.5 | ) | 28.3 | 32.0 | 99.8 | |||||||||||
Net income | 399.3 | 39.8 | 941.6 | 249.2 | ||||||||||||
Net income attributable to non-controlling interest | 22.0 | 37.7 | 93.9 | 117.0 | ||||||||||||
Net income attributable to controlling interest | $ | 377.3 | $ | 2.1 | $ | 847.7 | $ | 132.2 | ||||||||
Amounts attributable to controlling interest | ||||||||||||||||
Net income (loss) from continuing operations attributable to controlling interest | $ | 377.4 | $ | (16.6 | ) | $ | 368.1 | $ | (88.6 | ) | ||||||
Net (loss) income from discontinued operations attributable to controlling interest | (0.1 | ) | 18.7 | 479.6 | 220.8 | |||||||||||
Net income attributable to controlling interest | $ | 377.3 | $ | 2.1 | $ | 847.7 | $ | 132.2 | ||||||||
Earnings Per Share | ||||||||||||||||
Basic earnings per share from continuing operations | $ | 11.52 | $ | (0.51 | ) | $ | 11.31 | $ | (2.75 | ) | ||||||
Basic earnings per share from discontinued operations | — | 0.57 | 14.74 | 6.85 | ||||||||||||
Basic earnings per share | $ | 11.52 | $ | 0.06 | $ | 26.05 | $ | 4.10 | ||||||||
Diluted earnings per share from continuing operations | $ | 11.51 | $ | (0.51 | ) | $ | 11.26 | $ | (2.75 | ) | ||||||
Diluted earnings per share from discontinued operations | — | 0.57 | 14.67 | 6.85 | ||||||||||||
Diluted earnings per share | $ | 11.51 | $ | 0.06 | $ | 25.93 | $ | 4.10 | ||||||||
Weighted Average Shares Outstanding | ||||||||||||||||
Basic | 32.7 | 32.3 | 32.5 | 32.2 | ||||||||||||
Diluted | 32.8 | 32.3 | 32.7 | 32.2 | ||||||||||||
SPECTRUM BRANDS HOLDINGS, INC. | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) | ||||||||
Nine Month Periods Ended | ||||||||
(in millions) | June 30, 2018 | June 30, 2017 | ||||||
Cash flows from operating activities | ||||||||
Net income | $ | 941.6 | $ | 249.2 | ||||
Income from discontinued operations, net of tax | 497.9 | 295.2 | ||||||
Net income from continuing operations | 443.7 | (46.0 | ) | |||||
Adjustments to reconcile net income to net cash from operating activities: | ||||||||
Depreciation and amortization | 99.4 | 94.3 | ||||||
Share based compensation | 6.4 | 28.5 | ||||||
Amortization of debt issuance costs and debt discount | 16.3 | 13.2 | ||||||
Write-off of unamortized discount and debt issuance costs | (0.6 | ) | 2.5 | |||||
Purchase accounting inventory adjustment | 0.8 | 0.8 | ||||||
Pet safety recall inventory write-off | 3.6 | 13.0 | ||||||
Dividends from subsidiaries classified as discontinued operations | 3.1 | 9.3 | ||||||
Deferred tax (benefit) expense | (497.9 | ) | 17.4 | |||||
Net changes in operating assets and liabilities |
(226.0 |
) |
(211.4 |
) | ||||
Net cash used by operating activities from continuing operations |
(151.2 |
) |
(78.4 |
) | ||||
Net cash provided by operating activities from discontinued operations |
94.8 |
308.5 |
||||||
Net cash (used) provided by operating activities | (56.4 | ) | 230.1 | |||||
Cash flows from investing activities | ||||||||
Purchases of property, plant and equipment | (49.2 | ) | (51.1 | ) | ||||
Proceeds from sales of property, plant and equipment | 2.8 |
3.6 |
||||||
Business acquisitions, net of cash acquired | — | (304.7 | ) | |||||
Proceeds from sale of insurance operations | 1,546.8 | — | ||||||
Net asset-based loan repayments | — | 29.8 | ||||||
Other investing activities, net | (0.4 | ) |
(1.2 |
) | ||||
Net cash provided (used) by investing activities from continuing operations | 1,500.0 | (323.6 | ) | |||||
Net cash used by investing activities from discontinued operations | (201.8 | ) | (991.3 | ) | ||||
Net cash provided (used) by investing activities | 1,298.2 | (1,314.9 | ) | |||||
Cash flows from financing activities | ||||||||
Proceeds from issuance of debt | 555.3 |
606.9 |
||||||
Payment of debt |
(1,007.6 |
) | (244.7 | ) | ||||
Payment of debt issuance costs | (0.4 | ) | (7.0 | ) | ||||
Purchase of subsidiary stock, net | (288.0 | ) | (165.9 | ) | ||||
Purchase of non-controlling interest | — | (12.6 | ) | |||||
Dividend paid by subsidiary to non-controlling interest | (28.4 | ) | (30.3 | ) | ||||
Share based award tax withholding payments, net of proceeds upon vesting | (24.3 | ) | (40.7 | ) | ||||
Other financing activities, net | 20.7 | 5.5 | ||||||
Net cash (used) provided by financing activities from continuing operations |
(772.7 |
) |
111.2 |
|||||
Net cash provided by financing activities from discontinued operations |
116.2 |
701.9 |
||||||
Net cash (used) provided by financing activities | (656.5 | ) | 813.1 | |||||
Effect of exchange rate changes on cash and cash equivalents | (3.1 | ) | (1.5 | ) | ||||
Net change in cash and cash equivalents | 582.2 | (273.2 | ) | |||||
Net change in cash and cash equivalents in discontinued operations | 37.7 | (74.2 | ) | |||||
Net change in cash and cash equivalents in continuing operations | 544.5 | (199.0 | ) | |||||
Cash and cash equivalents, beginning of period | 270.1 | 465.2 | ||||||
Cash and cash equivalents, end of period | $ | 814.6 | $ | 266.2 | ||||
SPECTRUM BRANDS HOLDINGS, INC. | ||||||
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited) | ||||||
(in millions) | June 30, 2018 | September 30, 2017 | ||||
Assets | ||||||
Cash and cash equivalents | $ | 814.6 | $ | 270.1 | ||
Trade receivables, net | 384.2 | 266.0 | ||||
Other receivables | 38.1 | 19.7 | ||||
Inventories | 546.7 | 496.3 | ||||
Prepaid expenses and other current assets | 69.1 | 54.8 | ||||
Current assets of business held for sale | 1,910.5 | 28,929.2 | ||||
Total current assets | 3,763.2 | 30,036.1 | ||||
Property, plant and equipment, net | 497.4 | 503.9 | ||||
Deferred charges and other | 418.0 | 43.7 | ||||
Goodwill | 2,269.4 | 2,277.1 | ||||
Intangible assets, net | 1,564.8 | 1,612.0 | ||||
Noncurrent assets of business held for sale | — | 1,376.9 | ||||
Total assets | $ | 8,512.8 | $ | 35,849.7 | ||
Liabilities and Shareholders' Equity | ||||||
Current portion of long-term debt | $ | 70.8 | $ | 161.4 | ||
Accounts payable | 348.3 | 373.1 | ||||
Accrued wages and salaries | 49.6 | 55.4 | ||||
Accrued interest |
75.7 |
78.0 | ||||
Other current liabilities |
130.6 |
125.8 | ||||
Current liabilities of business held for sale | 525.3 | 26,851.3 | ||||
Total current liabilities | 1,200.3 | 27,645.0 | ||||
Long-term debt, net of current portion | 5,189.4 | 5,543.7 | ||||
Deferred income taxes | 314.2 | 493.2 | ||||
Other long-term liabilities | 119.1 | 64.8 | ||||
Noncurrent liabilities of business held for sale | — | 156.1 | ||||
Total liabilities | 6,823.0 | 33,902.8 | ||||
Shareholders' equity | 1,052.4 | 758.0 | ||||
Noncontrolling interest | 637.4 | 1,188.9 | ||||
Total equity | 1,689.8 | 1,946.9 | ||||
Total liabilities and equity | $ | 8,512.8 | $ | 35,849.7 | ||
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
ADJUSTED DILUTED EPS
We define adjusted diluted EPS as reported diluted EPS excluding the
effect of one-time, non-recurring activity and volatility associated
with our income tax expense. The Company believes that adjusted diluted
EPS provides further insight and comparability in operating performance
as it eliminates the effects of certain items that are not comparable
from one period to the next. Adjustments to diluted EPS include (1)
proforma adjustment reflecting the change in weighted average shares for
the share exchange associated with the HRG Merger, including income
attributable to non-controlling interest in Spectrum recognized prior to
the consolidation of the shareholder groups; (2) acquisition and
integration costs that consist of transaction costs from nonrecurring
acquisition transactions during the period or subsequent integration
related project costs directly associated with the acquired business
further summarized below; (3) restructuring and related costs, which
consist of project costs associated with restructuring initiatives
across the segments further summarized below; (4) purchase accounting
inventory adjustments recognized in earnings subsequent to an
acquisition; (5) non-cash asset impairments or write-offs realized; (6)
estimated costs for a non-recurring voluntary recall of rawhide product
by the PET segment; (7) transaction costs associated with the HRG
Merger; (8) non-recurring HRG net operating costs that consist of
redundant and duplicative costs that are expected to be eliminated post
merger including compensation and benefits, directors fees, professional
fees, insurance, public company costs, among others, including interest
and other non-recurring income; (9) net operating costs associated with
Salus; (10) interest costs associated with HRG-originated debt through
the HRG Merger; and (10) other. During the three and nine month periods
ended
Three Month Period Ended June 30, 2018 | Three Month Period Ended June 30, 2017 | |||||||||||||||||||||||
Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | |||||||||||||||||||
Diluted earnings per share, as reported | $ | 11.51 | $ | — | $ | 11.51 | $ | (0.51 | ) | $ | 0.57 | $ | 0.06 | |||||||||||
Adjustments: | ||||||||||||||||||||||||
HRG Merger share exchange proforma adjustment | (4.02 | ) | (0.07 | ) | (4.09 | ) | 0.58 | (0.05 | ) | 0.53 | ||||||||||||||
Acquisition and integration related charges | 0.04 | 0.45 | 0.49 | 0.09 | 0.01 | 0.10 | ||||||||||||||||||
Restructuring and related charges | 0.47 | 0.01 | 0.48 | 0.37 | — | 0.37 | ||||||||||||||||||
Debt refinancing costs | — | — | — | 0.02 | — | 0.02 | ||||||||||||||||||
Purchase accounting inventory adjustment | — | — | — | 0.01 | — | 0.01 | ||||||||||||||||||
Pet safety recall | 0.10 | — | 0.10 | 0.44 | — | 0.44 | ||||||||||||||||||
HRG merger related transaction costs | 0.06 | — | 0.06 | 0.03 | — | 0.03 | ||||||||||||||||||
Non-recurring HRG net operating costs | 0.03 | — | 0.03 | 0.15 | — | 0.15 | ||||||||||||||||||
Salus | — | — | — | 0.01 | — | 0.01 | ||||||||||||||||||
HRG interest expense | 0.37 | — | 0.37 | 0.64 | — | 0.64 | ||||||||||||||||||
Other | 0.06 | — | 0.06 | — | — | — | ||||||||||||||||||
Income tax adjustment | (6.86 | ) | (0.20 | ) | (7.06 | ) | (0.41 | ) | 0.04 | (0.37 | ) | |||||||||||||
Total Adjustments | (9.75 | ) | 0.19 | (9.56 | ) | 1.93 | — | 1.93 | ||||||||||||||||
Diluted earnings per share, as adjusted | $ | 1.76 | $ | 0.19 | $ | 1.95 | $ | 1.42 | $ | 0.57 | $ | 1.99 | ||||||||||||
Nine Month Period Ended June 30, 2018 | Nine Month Period Ended June 30, 2017 | |||||||||||||||||||||||
Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | |||||||||||||||||||
Diluted earnings per share, as reported | $ | 11.26 | $ | 14.67 | $ | 25.93 | $ | (2.75 | ) | $ | 6.85 | $ | 4.10 | |||||||||||
Adjustments: | ||||||||||||||||||||||||
HRG Merger share exchange proforma adjustment | (3.19 | ) | (5.71 | ) | (8.90 | ) | 1.94 | (2.24 | ) | (0.30 | ) | |||||||||||||
Acquisition and integration related charges | 0.22 | 0.90 | 1.12 | 0.20 | 0.06 | 0.26 | ||||||||||||||||||
Restructuring and related charges | 1.25 | 0.03 | 1.28 | 0.55 | 0.02 | 0.57 | ||||||||||||||||||
Debt refinancing costs | — | — | — | 0.15 | — | 0.15 | ||||||||||||||||||
Purchase accounting inventory adjustment | 0.02 | — | 0.02 | 0.01 | — | 0.01 | ||||||||||||||||||
Pet safety recall | 0.30 | — | 0.30 | 0.44 | — | 0.44 | ||||||||||||||||||
HRG merger related transaction costs | 0.40 | — | 0.40 | 0.07 | — | 0.07 | ||||||||||||||||||
Non-recurring HRG net operating costs | 0.24 | — | 0.24 | 0.59 | — | 0.59 | ||||||||||||||||||
Salus | 0.02 | — | 0.02 | 0.09 | — | 0.09 | ||||||||||||||||||
HRG interest expense | 1.50 | — | 1.50 | 1.95 | — | 1.95 | ||||||||||||||||||
Other | 0.06 | — | 0.06 | — | — | — | ||||||||||||||||||
Income tax adjustment | (9.36 | ) | (2.38 | ) | (11.74 | ) | (0.57 | ) | (0.27 | ) | (0.84 | ) | ||||||||||||
Total Adjustments | (8.54 | ) | (7.16 | ) | (15.70 | ) | 5.42 | (2.43 | ) | 2.99 | ||||||||||||||
Diluted earnings per share, as adjusted | $ | 2.72 | $ | 7.51 | $ | 10.23 | $ | 2.67 | $ | 4.42 | $ | 7.09 | ||||||||||||
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
ADJUSTED DILUTED EPS (continued)
The weighted average shares and adjusted earnings per share data are
adjusted for all periods to reflect the reverse stock split and share
exchange because of the HRG Merger, which closed on
Three Month Periods Ended | Nine Month Periods Ended | |||||||||||
(in millions, except per share amounts) | June 30, 2018 | June 30, 2017 | June 30, 2018 | June 30, 2017 | ||||||||
Basic | ||||||||||||
Spectrum weighted average shares | 55.3 | 58.7 | 56.7 | 58.9 | ||||||||
Spectrum weighted average shares owned by HRG | 34.3 | 34.3 | 34.3 | 34.3 | ||||||||
Spectrum weighted average shares owned by third parties (A) | 21.0 | 24.3 | 22.4 | 24.6 | ||||||||
HRG weighted average shares | 203.0 | 200.4 | 201.8 | 199.8 | ||||||||
HRG share conversion at 1 to 0.1613 (B) | 32.7 | 32.3 | 32.5 | 32.2 | ||||||||
Total weighted average shares (A + B) | 53.7 | 56.6 | 54.9 | 56.8 | ||||||||
Diluted | ||||||||||||
Spectrum weighted average shares | 55.4 | 58.9 | 56.7 | 59.1 | ||||||||
Spectrum weighted average shares owned by HRG | 34.3 | 34.3 | 34.3 | 34.3 | ||||||||
Spectrum weighted average shares owned by third parties (A) | 21.1 | 24.6 | 22.4 | 24.8 | ||||||||
HRG weighted average shares | 203.3 | 202.6 | 202.7 | 202.4 | ||||||||
HRG share conversion at 1 to 0.1613 (B) | 32.7 | 32.6 | 32.7 | 32.6 | ||||||||
Total weighted average shares (A + B) | 53.8 | 57.2 | 55.1 | 57.4 | ||||||||
The following summarizes the acquisition and integration related charges
incurred by the Company for the three and nine month periods ended
Three Month Periods Ended June 30, 2018 | Three Month Periods Ended June 30, 2017 | |||||||||||||||||
(in millions) | Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | ||||||||||||
HHI Business | $ | 0.9 | $ | — | $ | 0.9 | $ | 1.8 | $ | — | $ | 1.8 | ||||||
PetMatrix | 0.8 | — | 0.8 | 1.7 | — | 1.7 | ||||||||||||
Armored AutoGroup | — | — | — | 0.3 | 0.3 | 0.6 | ||||||||||||
Other | 0.6 | 24.3 | 24.9 | 1.4 | 0.3 | 1.7 | ||||||||||||
Total acquisition and integration related charges | $ | 2.3 | $ | 24.3 | $ | 26.6 | $ | 5.2 | $ | 0.6 | $ | 5.8 | ||||||
Nine Month Periods Ended June 30, 2018 | Nine Month Periods Ended June 30, 2017 | |||||||||||||||||
(in millions) | Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | ||||||||||||
HHI Business | $ | 5.5 | $ | — | $ | 5.5 | $ | 5.7 | $ | — | $ | 5.7 | ||||||
PetMatrix | 4.5 | — | 4.5 | 2.0 | — | 2.0 | ||||||||||||
Armored AutoGroup | 0.6 | — | 0.6 | 2.1 | 0.9 | 3.0 | ||||||||||||
Other | 1.4 | 49.4 | 50.8 | 1.8 | 2.5 | 4.3 | ||||||||||||
Total acquisition and integration related charges | $ | 12.0 | $ | 49.4 | $ | 61.4 | $ | 11.6 | $ | 3.4 | $ | 15.0 | ||||||
The following summarizes the restructuring and related charges incurred
by the Company for the three and nine month periods ended
Three Month Periods Ended June 30, 2018 | Three Month Periods Ended June 30, 2017 | |||||||||||||||||||
(in millions) | Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | ||||||||||||||
HHI distribution center consolidation | $ | 11.6 | $ | — | $ | 11.6 | $ | 9.0 | $ | — | $ | 9.0 | ||||||||
GAC business rationalization initiative | 6.3 | — | 6.3 | 12.8 | — | 12.8 | ||||||||||||||
PET rightsizing initiative | 3.1 | — | 3.1 | 2.2 | — | 2.2 | ||||||||||||||
Other restructuring activities | 4.4 | 0.4 | 4.8 | (2.8 | ) | — | (2.8 | ) | ||||||||||||
Total restructuring and related charges | $ | 25.4 | $ | 0.4 | $ | 25.8 | $ | 21.2 | $ | — | $ | 21.2 | ||||||||
Nine Month Periods Ended June 30, 2018 | Nine Month Periods Ended June 30, 2017 | |||||||||||||||||||
(in millions) | Cont. Ops | Disc. Ops | Total | Cont. Ops | Disc. Ops | Total | ||||||||||||||
HHI distribution center consolidation | $ | 40.4 | $ | — | $ | 40.4 | $ | 9.1 | $ | — | $ | 9.1 | ||||||||
GAC business rationalization initiative | 13.5 | — | 13.5 | 19.8 | — | 19.8 | ||||||||||||||
PET rightsizing initiative | 7.1 | — | 7.1 | 2.8 | — | 2.8 | ||||||||||||||
Other restructuring activities | 8.0 | 1.4 | 9.4 | (0.4 | ) | 1.4 | 1.0 | |||||||||||||
Total restructuring and related charges | $ | 69.0 | $ | 1.4 | $ | 70.4 | $ | 31.3 | $ | 1.4 | $ | 32.7 | ||||||||
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
NET SALES AND ORGANIC NET SALES
The following is a summary of net sales by segment for the three and
nine month periods ended
Three Month Periods Ended | Nine Month Periods Ended | ||||||||||||||||||||||||
(in millions, except %) | June 30, 2018 | June 30, 2017 | Variance | June 30, 2018 | June 30, 2017 | Variance | |||||||||||||||||||
HHI | $ | 372.4 | $ | 324.7 | 47.7 | 14.7 | % | $ | 1,016.8 | $ | 927.2 | 89.6 | 9.7 | % | |||||||||||
PET | 194.7 | 190.0 | 4.7 | 2.5 | % | 608.3 | 576.0 | 32.3 | 5.6 | % | |||||||||||||||
H&G | 203.2 | 192.4 | 10.8 | 5.6 | % | 370.6 | 374.2 | (3.6 | ) | (1.0 | %) | ||||||||||||||
GAC | 175.2 | 155.8 | 19.4 | 12.5 | % | 362.4 | 344.2 | 18.2 | 5.3 | % | |||||||||||||||
Total | $ | 945.5 | $ | 862.9 | 82.6 | 9.6 | % | $ | 2,358.1 | $ | 2,221.6 | 136.5 | 6.1 | % | |||||||||||
We define organic net sales as reported net sales excluding the effect
of changes in foreign currency exchange rates and acquisitions. We
believe this non-GAAP measure provides useful information to investors
because it reflects regional and operating segment performance from our
activities without the effect of changes in currency exchange rate
and/or acquisitions. We use organic net sales as one measure to monitor
and evaluate our regional and segment performance. Organic growth is
calculated by comparing organic net sales to reported net sales in the
prior year. The effect of changes in currency exchange rates is
determined by translating the period’s net sales using the currency
exchange rates that were in effect during the prior period. Net sales
are attributed to the geographic regions based on the country of
destination. We exclude net sales from acquired businesses in the
current year for which there are no comparable sales in the prior
period. The following is a reconciliation of reported sales to organic
sales for the three and nine month periods ended
June 30, 2018 | |||||||||||||||||||||||||||
Net Sales | |||||||||||||||||||||||||||
|
Excluding | ||||||||||||||||||||||||||
Effect of | Effect of | ||||||||||||||||||||||||||
Three month periods ended |
Changes in | Changes in | Effect of | Organic | Net Sales | ||||||||||||||||||||||
(in millions, except %) |
Net Sales | Currency | Currency | Acquisitions | Net Sales | June 30, 2017 | Variance | ||||||||||||||||||||
HHI | 372.4 | (1.3 | ) | 371.1 | — | 371.1 | 324.7 | 46.4 | 14.3 | % | |||||||||||||||||
PET | 194.7 | (2.9 | ) | 191.8 | (14.5 | ) | 177.3 | 190.0 | (12.7 | ) | (6.7 | %) | |||||||||||||||
H&G | 203.2 | — | 203.2 | — | 203.2 | 192.4 | 10.8 | 5.6 | % | ||||||||||||||||||
GAC | 175.2 | (0.7 | ) | 174.5 | — | 174.5 | 155.8 | 18.7 | 12.0 | % | |||||||||||||||||
Total | $ | 945.5 | $ | (4.9 | ) | $ | 940.6 | $ | (14.5 | ) | $ | 926.1 | $ | 862.9 | 63.2 | 7.3 | % | ||||||||||
June 30, 2018 | |||||||||||||||||||||||||||
Net Sales | |||||||||||||||||||||||||||
|
Excluding | ||||||||||||||||||||||||||
|
Effect of | Effect of | |||||||||||||||||||||||||
Nine month periods ended |
Changes in | Changes in | Effect of | Organic | Net Sales | ||||||||||||||||||||||
(in millions, except %) |
Net Sales | Currency | Currency | Acquisitions | Net Sales | June 30, 2017 | Variance | ||||||||||||||||||||
HHI | 1,016.8 | (5.9 | ) | 1,010.9 | — | 1,010.9 | 927.2 | 83.7 | 9.0 | % | |||||||||||||||||
PET | 608.3 | (16.3 | ) | 592.0 | (64.5 | ) | 527.5 | 576.0 | (48.5 | ) | (8.4 | %) | |||||||||||||||
H&G | 370.6 | — | 370.6 | — | 370.6 | 374.2 | (3.6 | ) | (1.0 | %) | |||||||||||||||||
GAC | 362.4 | (2.6 | ) | 359.8 | — | 359.8 | 344.2 | 15.6 | 4.5 | % | |||||||||||||||||
Total | $ | 2,358.1 | $ | (24.8 | ) | $ | 2,333.3 | $ | (64.5 | ) | $ | 2,268.8 | $ | 2,221.6 | 47.2 | 2.1 | % | ||||||||||
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ORGANIC ADJUSTED EBITDA
Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation,
Amortization) is a non-GAAP metric used by management that we believe
provides useful information to investors because it reflects ongoing
operating performance and trends of our segments excluding certain
non-cash based expenses and/or non-recurring items during each of the
comparable periods and facilitates comparisons between peer companies
since interest, taxes, depreciation and amortization can differ greatly
between organizations as a result of differing capital structures and
tax strategies. Further, adjusted EBITDA is a measure used for
determining the Company’s debt covenant. EBITDA is calculated by
excluding the Company’s income tax expense, interest expense,
depreciation expense and amortization expense (from intangible assets)
from net income. Adjusted EBITDA further excludes: (1) share based
compensation expense as it is a non-cash based compensation cost,
including HRG share based compensation expense; (2) acquisition and
integration costs that consist of transaction costs from acquisition
transactions during the period, or subsequent integration related
project costs directly associated with the acquired business as
previously summarized; (3) restructuring and related costs, which
consist of project costs associated with restructuring initiatives as
previously summarized; (4) non-cash purchase accounting inventory
adjustments recognized in earnings subsequent to an acquisition; (5)
non-cash asset impairments or write-offs realized; (6) estimated costs
for a non-recurring voluntary recall of rawhide product by the PET
segment; (7) transaction costs associated with the HRG Merger; (8)
non-recurring HRG net operating costs that consist of redundant and
duplicative costs that are expected to be eliminated post merger
including compensation and benefits, directors fees, professional fees,
insurance, public company costs, among others, including interest and
other non-recurring income; (9) net operating costs associated with
Salus; (10) other. During the three and nine month periods ended
Three month period ended June 30, 2018 (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||
Net income from continuing operations | $ | 52.1 | $ | 14.4 | $ | 52.2 | $ | 38.2 | $ | 246.0 | $ | 402.9 | ||||||
Income tax benefit | — | — | — | — | (337.8) | (337.8) | ||||||||||||
Interest expense | — | — | — | — | 63.5 | 63.5 | ||||||||||||
Depreciation and amortization | 8.9 | 10.6 | 4.7 | 4.3 | 3.7 | 32.2 | ||||||||||||
EBITDA | 61.0 | 25.0 | 56.9 | 42.5 | (24.6) | 160.8 | ||||||||||||
Share based compensation | — | — | — | — | 5.3 | 5.3 | ||||||||||||
Acquisition and integration related charges | 0.9 | 1.1 | — | — | 0.3 | 2.3 | ||||||||||||
Restructuring and related charges | 12.0 | 3.7 | 0.1 | 7.6 | 2.0 | 25.4 | ||||||||||||
Pet safety recall | — | 5.1 | — | — | — | 5.1 | ||||||||||||
HRG merger related transaction charges | — | — | — | — | 3.1 | 3.1 | ||||||||||||
Non-recurring HRG operating costs and interest income | — | — | — | — | 1.2 | 1.2 | ||||||||||||
Salus | — | — | — | — | (0.1) | (0.1) | ||||||||||||
Other | — | — | — | — | 3.3 | 3.3 | ||||||||||||
Adjusted EBITDA | $ | 73.9 | $ | 34.9 | $ | 57.0 | $ | 50.1 | $ | (9.5) | $ | 206.4 | ||||||
Net Sales | 372.4 | 194.7 | 203.2 | 175.2 | — | 945.5 | ||||||||||||
Adjusted EBITDA Margin | 19.8% | 17.9% | 28.1% | 28.6% | — | 21.8% | ||||||||||||
Three month period ended June 30, 2017 (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||
Net income from continuing operations | $ | 44.4 | $ | (5.4) | $ | 55.3 | $ | 32.5 | $ | (123.0) | $ | 3.8 | ||||||
Income tax expense | — | — | — | — | 19.5 | 19.5 | ||||||||||||
Interest expense | — | — | — | — | 76.1 | 76.1 | ||||||||||||
Depreciation and amortization | 9.8 | 10.8 | 4.2 | 5.1 | 3.0 | 32.9 | ||||||||||||
EBITDA | 54.2 | 5.4 | 59.5 | 37.6 | (24.4) | 132.3 | ||||||||||||
Share based compensation | — | — | — | — | 5.0 | 5.0 | ||||||||||||
Acquisition and integration related charges | 1.8 | 3.0 | — | 0.3 | 0.1 | 5.2 | ||||||||||||
Restructuring and related charges | 6.2 | 2.0 | — | 12.8 | 0.2 | 21.2 | ||||||||||||
Inventory acquisition step-up | — | 0.8 | — | — | — | 0.8 | ||||||||||||
Pet safety recall | — | 24.9 | — | — | — | 24.9 | ||||||||||||
HRG merger related transaction charges | — | — | — | — | 1.4 | 1.4 | ||||||||||||
Non-recurring HRG operating costs and interest income | — | — | — | — | 7.8 | 7.8 | ||||||||||||
Salus | — | — | — | — | 0.7 | 0.7 | ||||||||||||
Adjusted EBITDA | $ | 62.2 | $ | 36.1 | $ | 59.5 | $ | 50.7 | $ | (9.2) | $ | 199.3 | ||||||
Net Sales | 324.7 | 190.0 | 192.4 | 155.8 | — | 862.9 | ||||||||||||
Adjusted EBITDA Margin | 19.2% | 19.0% | 30.9% | 32.5% | — | 23.1% | ||||||||||||
Organic Adjusted EBITDA (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||
Adjusted EBITDA - three month period ended July 1, 2018 | $ | 73.9 | $ | 34.9 | $ | 57.0 | $ | 50.1 | $ | (9.5) | $ | 206.4 | ||||||
Effect of change in foreign currency | (1.8) | 0.6 | — | 0.5 | 0.3 | (0.4) | ||||||||||||
Net EBITDA Excluding Effect of Changes in Currency | 72.1 | 35.5 | 57.0 | 50.6 | (9.2) | 206.0 | ||||||||||||
Effect of acquisitions | — | (5.6) | — | — | — | (5.6) | ||||||||||||
Organic Adjusted EBITDA | 72.1 | 29.9 | 57.0 | 50.6 | (9.2) | 200.4 | ||||||||||||
Adjusted EBITDA - three month period ended July 2, 2017 | 62.2 | 36.1 | 59.5 | 50.7 | (9.2) | 199.3 | ||||||||||||
Increase (Decrease) in Organic Adjusted EBITDA | $ | 9.9 | $ | (6.2) | $ | (2.5) | $ | (0.1) | $ | — | $ | 1.1 | ||||||
Increase (Decrease) in Organic Adjusted EBITDA (%) | 15.9% | (17.2%) | (4.2%) | (0.2%) | 0.0% | 0.6% |
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ORGANIC ADJUSTED EBITDA (continued)
The following is a reconciliation of reported net income to adjusted
EBITDA for the nine month periods ended
Nine month period ended June 30, 2018 (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||||||||
Net income from continuing operations | $ | 101.8 | $ | 42.5 | $ | 73.4 | $ | 57.3 | $ | 168.7 | $ | 443.7 | ||||||||||||
Income tax benefit | — | — | — | — | (464.9 | ) | (464.9 | ) | ||||||||||||||||
Interest expense | — | — | — | — | 206.6 | 206.6 | ||||||||||||||||||
Depreciation and amortization | 31.4 | 31.7 | 14.0 | 12.1 | 10.2 | 99.4 | ||||||||||||||||||
EBITDA | 133.2 | 74.2 | 87.4 | 69.4 | (79.4 | ) | 284.8 | |||||||||||||||||
Share based compensation | — | — | — | — | 6.4 | 6.4 | ||||||||||||||||||
Acquisition and integration related charges | 5.5 | 5.2 | — | 0.6 | 0.7 | 12.0 | ||||||||||||||||||
Restructuring and related charges | 40.8 | 8.1 | 0.3 | 14.7 | 5.1 | 69.0 | ||||||||||||||||||
Inventory acquisition step-up | — | 0.8 | — | — | — | 0.8 | ||||||||||||||||||
Pet safety recall | — | 16.3 | — | — | — | 16.3 | ||||||||||||||||||
HRG merger related transaction charges | — | — | — | — | 22.0 | 22.0 | ||||||||||||||||||
Non-recurring HRG operating costs and interest income | — | — | — | — | 11.9 | 11.9 | ||||||||||||||||||
Salus | — | — | — | — | 1.2 | 1.2 | ||||||||||||||||||
Other | — | — | — | — | 3.3 | 3.3 | ||||||||||||||||||
Adjusted EBITDA | $ | 179.5 | $ | 104.6 | $ | 87.7 | $ | 84.7 | $ | (28.8 | ) | $ | 427.7 | |||||||||||
Net Sales | 1,016.8 | 608.3 | 370.6 | 362.4 | — | 2,358.1 | ||||||||||||||||||
Adjusted EBITDA Margin | 17.7 | % | 17.2 | % | 23.7 | % | 23.4 | % | — | 18.1 | % | |||||||||||||
Nine month period ended June 30, 2017 (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||||||||
Net income from continuing operations | $ | 136.7 | $ | 34.1 | $ | 88.4 | $ | 80.1 | $ | (385.3 | ) | $ | (46.0 | ) | ||||||||||
Income tax expense | — | — | — | — | 49.1 | 49.1 | ||||||||||||||||||
Interest expense | — | — | — | — | 232.4 | 232.4 | ||||||||||||||||||
Depreciation and amortization | 28.0 | 31.6 | 12.4 | 13.9 | 8.4 | 94.3 | ||||||||||||||||||
EBITDA | 164.7 | 65.7 | 100.8 | 94.0 | (95.4 | ) | 329.8 | |||||||||||||||||
Share based compensation | — | — | — | — | 28.5 | 28.5 | ||||||||||||||||||
Acquisition and integration related charges | 5.6 | 3.6 | — | 2.1 | 0.3 | 11.6 | ||||||||||||||||||
Restructuring and related charges | 7.7 | 3.7 | — | 19.8 | 0.1 | 31.3 | ||||||||||||||||||
Inventory acquisition step-up | — | 0.8 | — | — | — | 0.8 | ||||||||||||||||||
Pet safety recall | — | 24.9 | — | — | — | 24.9 | ||||||||||||||||||
HRG merger related transaction charges | — | — | — | — | 4.2 | 4.2 | ||||||||||||||||||
Non-recurring HRG operating costs and interest income | — | — | — | — | 28.6 | 28.6 | ||||||||||||||||||
Salus | — | — | — | — | 5.0 | 5.0 | ||||||||||||||||||
Adjusted EBITDA | $ | 178.0 | $ | 98.7 | $ | 100.8 | $ | 115.9 | $ | (28.7 | ) | $ | 464.7 | |||||||||||
Net Sales | 927.2 | 576.0 | 374.2 | 344.2 | — | 2,221.6 | ||||||||||||||||||
Adjusted EBITDA Margin | 19.2 | % | 17.1 | % | 26.9 | % | 33.7 | % | — | 20.9 | % | |||||||||||||
Organic Adjusted EBITDA (in millions, except %) | HHI | PET | H&G | GAC | Corporate | Consolidated | ||||||||||||||||||
Adjusted EBITDA - nine month period ended July 1, 2018 | $ | 179.5 | $ | 104.6 | $ | 87.7 | $ | 84.7 | $ | (28.8 | ) | $ | 427.7 | |||||||||||
Effect of change in foreign currency | 0.2 | (0.5 | ) | — | 0.1 | 1.0 | 0.8 | |||||||||||||||||
Net EBITDA Excluding Effect of Changes in Currency | 179.7 | 104.1 | 87.7 | 84.8 | (27.8 | ) | 428.5 | |||||||||||||||||
Effect of acquisitions | — | (22.8 | ) | — | — | — | (22.8 | ) | ||||||||||||||||
Organic Adjusted EBITDA | 179.7 | 81.3 | 87.7 | 84.8 | (27.8 | ) | 405.7 | |||||||||||||||||
Adjusted EBITDA - six month period ended July 2, 2017 | 178.0 | 98.7 | 100.8 | 115.9 | (28.7 | ) | 464.7 | |||||||||||||||||
Increase (Decrease) in Organic Adjusted EBITDA | $ | 1.7 | $ | (17.4 | ) | $ | (13.1 | ) | $ | (31.1 | ) | $ | 0.9 | $ | (59.0 | ) | ||||||||
Increase (Decrease) in Organic Adjusted EBITDA (%) | 1.0 | % | (17.6 | %) | (13.0 | %) | (26.8 | %) | (3.1 | %) | (12.7 | %) | ||||||||||||
OTHER SUPPLEMENTAL INFORMATION (Unaudited)
ADJUSTED EBITDA, ADJUSTED EBITDA MARGIN, AND ORGANIC ADJUSTED EBITDA (continued)
The following is a reconciliation of forecasted adjusted EBITDA for the
fiscal year ending
(in millions) | Cont. Ops | Disc Ops | Total | ||||||
Net income | $ | 207 - 221 | $ | 78 - 86 | $ | 285 - 307 | |||
Income tax (benefit) expense | (78) - (75) | (7) - (5) | (85) - (80) | ||||||
Interest expense | 161 - 167 | 54 - 58 | 215 - 225 | ||||||
Depreciation and amortization | 122 - 127 | 73 - 78 | 195 - 205 | ||||||
EBITDA | 418 - 435 | 201 - 211 | 619 - 646 | ||||||
Share based compensation | 18 | 2 | 20 | ||||||
Acquisition and integration related charges | 14 - 15 | 59 - 61 | 73 - 76 | ||||||
Restructuring and related charges | 88 - 90 | 2 | 90 - 92 | ||||||
Inventory acquisition step-up | 1 | — | 1 | ||||||
Pet safety recall | 16 - 18 | — | 16 - 18 | ||||||
Other | 41 - 43 | — | 41 - 43 | ||||||
Adjusted EBITDA | $ | 600 - 617 | $ | 265 - 275 | $ | 865 - 892 | |||
ADJUSTED FREE CASH FLOW
Our definition of adjusted free cash flow, which is a non-GAAP financial
measure, takes into consideration capital investments required to
maintain the operations of our businesses and execute our strategy. We
believe adjusted free cash flow provides useful information to investors
regarding our ability to generate cash from business operations that is
available for acquisitions and other investments, service of debt
principal, dividends and share repurchases and meet its working capital
requirements. Our definition of adjusted free cash flow may be different
from definitions used by other companies. We also use adjusted free cash
flow, as defined, as one measure to monitor and evaluate performance.
The following is a reconciliation of the Company’s forecasted adjusted
free cash flow for the fiscal year ending
(in millions) | September 30, 2018 | September 30, 2017 | ||||
Net cash flow from operating activities | $ | 495 - 520 | $ | 665 | ||
GBA divestiture transaction costs | 40 - 45 | — | ||||
HRG merger transaction costs | 35 - 40 | — | ||||
Cash interest charges related to refinancing | — | 5 | ||||
Stanley settlement payment | — | 23 | ||||
Rawhide recall | 10 - 15 | 9 | ||||
Purchases of property, plant and equipment | (100) - (110) | (115) | ||||
Adjusted free cash flow | $ | 485 - 505 | $ | 587 | ||
View source version on businesswire.com: https://www.businesswire.com/news/home/20180726005220/en/
Source:
Spectrum Brands Holdings, Inc.
Investor/Media Contact:
Dave
Prichard
608-278-6141